John Sterling
Editor-in-Chief at Genetic Engineering & Biotechnology News
Editor in Chief of Genetic Engineering & Biotechnology News (GEN) since 1985; BS degree in biology from CCNY and MA in journalism from Univ of Minnesota
Articles
-
1 day ago |
genengnews.com | John Sterling |Daniel R Getts
Credit: Myeloid Therapeutics Imagine dedicating your life to science, only to see your work undermined by conspiracy theories and political noise. Case in point: the Trump administration recently canceled over $766 million in federal funding allocated to Moderna to develop an mRNA-based H5N1 bird flu vaccine. Despite promising early results, the program was abruptly halted. Health Secretary Robert F. Kennedy Jr., a vocal critic of mRNA, cited concerns about safety and transparency.
-
2 days ago |
genengnews.com | John Sterling
The National Multiple Sclerosis Society (NMSS) announced a number of new funding opportunities aimed to bolster MS research and training. Support originates both from the Society and outside entities. The move comes as the White House continues to lobby Congress to significantly cut funding for public health and biomedical research in the 2026 fiscal year that begins in October.
-
3 days ago |
genengnews.com | John Sterling
The Medicines and Healthcare products Regulatory Agency (MHRA) has published the U.K.’s first official guidance to support the safe development and use of phage therapies. The guidance aims to help researchers and companies develop phage-based medicines that meet U.K. safety, quality and efficacy standards so they can be made available to patients who need them most.
-
3 days ago |
genengnews.com | John Sterling
Medicines Discovery Catapult (MDC) and the Francis Crick Institute formed a strategic partnership to support the delivery of KQ Labs, founded and hosted by the Crick. The KQ Labs program is an annual five-month accelerator for up to ten U.K.-based startups building science-backed, data-driven, scalable solutions in drug discovery, digital health, and precision medicine. Since 2018, KQ Labs has supported 70 startups, and KQ Labs alumni have raised over £219 million in investment to date.
-
5 days ago |
genengnews.com | John Sterling
Home Topics Bioprocessing Bora Adds Automated Fill/Finish Line Credit: Luza Studios/Getty Images Credit: Luza Studios/Getty Images Taiwan-based Bora Pharmaceuticals plans to add further sterile fill/finish capacity at its facility in Baltimore, MD. Installation of a new AST GENiSYS® C automated vial, syringe, and cartridge line will take place over the course of the next year.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 274
- Tweets
- 31
- DMs Open
- No
Genetic Engineering & Biotechnology News (GEN) is looking for researchers and science students interested in exploring science writing as interns putting together short daily news stories. For details, contact John Sterling, Editor in Chief, at [email protected]
.@GENbio is looking for biotech, science, and pharma freelance writers in the US, Europe, Asia, and So America. Background in science essential and 1-2 years writing exp required. Email resume & writing samples to [email protected]
BIG #BlackInGenetics is an organization dedicated to amplifying the voices and work of Black-identifying geneticists across the U.S. and beyond. This is #Blackingeneticsweek.@GENbio